Colony Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-28,735
| Closed | -$1.44M | – | 811 |
|
|
2021
Q3 | $1.44M | Buy |
28,735
+122
| +0.4% | +$6.11K | 0.03% | 361 |
|
|
2021
Q2 | $1.8M | Buy |
28,613
+413
| +1% | +$26K | 0.04% | 309 |
|
|
2021
Q1 | $2.62M | Buy |
28,200
+1,950
| +7% | +$181K | 0.06% | 268 |
|
|
2020
Q4 | $2.35M | Buy |
26,250
+4,714
| +22% | +$422K | 0.05% | 259 |
|
|
2020
Q3 | $2.23M | Sell |
21,536
-5,773
| -21% | -$596K | 0.06% | 251 |
|
|
2020
Q2 | $2.16M | Sell |
27,309
-499
| -2% | -$39.5K | 0.06% | 240 |
|
|
2020
Q1 | $1.61M | Sell |
27,808
-1,560
| -5% | -$90.3K | 0.05% | 270 |
|
|
2019
Q4 | $1.58M | Sell |
29,368
-425
| -1% | -$22.9K | 0.04% | 327 |
|
|
2019
Q3 | $1.56M | Sell |
29,793
-97
| -0.3% | -$5.07K | 0.05% | 299 |
|
|
2019
Q2 | $1.44M | Buy |
29,890
+65
| +0.2% | +$3.14K | 0.05% | 318 |
|
|
2019
Q1 | $1.51M | Sell |
29,825
-1,785
| -6% | -$90.2K | 0.06% | 242 |
|
|
2018
Q4 | $1.87M | Sell |
31,610
-895
| -3% | -$53.1K | 0.09% | 189 |
|
|
2018
Q3 | $2.14M | Sell |
32,505
-263
| -0.8% | -$17.3K | 0.11% | 174 |
|
|
2018
Q2 | $1.65M | Sell |
32,768
-65
| -0.2% | -$3.28K | 0.09% | 217 |
|
|
2018
Q1 | $1.73M | Buy |
32,833
+950
| +3% | +$50K | 0.09% | 208 |
|
|
2017
Q4 | $1.48M | Buy |
+31,883
| New | +$1.48M | 0.09% | 212 |
|